| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 49.498 | 208.207 | 184.367 | 103.318 | 128.016 | 18.577 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 49.499 | 210.847 | 186.263 | 104.368 | 128.471 | 19.930 | 431 | 433 |
| Total Expenses - EUR | 0 | 0 | 78.943 | 150.924 | 202.070 | 56.378 | 39.394 | 23.409 | 7.178 | 639 |
| Gross Profit/Loss - EUR | 0 | 0 | -29.443 | 59.923 | -15.807 | 47.990 | 89.077 | -3.480 | -6.747 | -206 |
| Net Profit/Loss - EUR | 0 | 0 | -30.928 | 53.628 | -21.347 | 44.892 | 85.686 | -3.975 | -6.747 | -206 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Juves Laboratories Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 135 | 134 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 45 | -89 | 40.828 | 159.306 | 145.716 | 162.146 | 245.448 | 182.567 | 176.232 | 174.593 |
| Inventories | 0 | 0 | 12.206 | 89.196 | 74.549 | 76.901 | 60.046 | 60.244 | 60.061 | 59.726 |
| Receivables | 0 | -134 | 27.730 | 45.004 | 54.253 | 67.057 | 168.689 | 115.862 | 115.613 | 114.995 |
| Cash | 45 | 45 | 892 | 25.106 | 16.914 | 18.187 | 16.713 | 6.462 | 558 | -127 |
| Shareholders Funds | 45 | 45 | -30.884 | 23.310 | 1.512 | 46.375 | 131.033 | 127.464 | 120.330 | 119.452 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 135 | 0 | 71.712 | 135.995 | 144.385 | 115.863 | 114.416 | 55.103 | 55.901 | 55.151 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Juves Laboratories Srl